Silence Therapeutics Plc Stock Price on December 31, 2022
| SLN Stock | USD 7.21 0.20 2.85% |
Below is the normalized historical share price chart for Silence Therapeutics PLC extending back to September 08, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Silence Therapeutics stands at 7.21, as last reported on the 26th of November, with the highest price reaching 7.70 and the lowest price hitting 7.07 during the day.
If you're considering investing in Silence Stock, it is important to understand the factors that can impact its price. Silence Therapeutics PLC owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.23, which indicates the firm had a -0.23% return per unit of risk over the last 3 months. Silence Therapeutics PLC exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Silence Therapeutics' Risk Adjusted Performance of (0.12), coefficient of variation of (598.42), and Variance of 35.18 to confirm the risk estimate we provide.
At this time, Silence Therapeutics' Stock Based Compensation is very stable compared to the past year. . At this time, Silence Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 26th of November 2024, Price Earnings To Growth Ratio is likely to grow to 1.72, while Price To Sales Ratio is likely to drop 18.97. Silence Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of September 2020 | 200 Day MA 19.9124 | 50 Day MA 16.8958 | Beta 1.29 |
Silence |
Sharpe Ratio = -0.2286
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SLN |
Estimated Market Risk
| 5.75 actual daily | 51 51% of assets are less volatile |
Expected Return
| -1.31 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.23 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Silence Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Silence Therapeutics by adding Silence Therapeutics to a well-diversified portfolio.
Price Book 2.7828 | Enterprise Value Ebitda (5.78) | Price Sales 43.5195 | Shares Float 78.8 M | Wall Street Target Price 53.6967 |
Related Headline
Mineralys Therapeutics, Headline on 9th of February 2023
Mineralys Therapeutics, exotic insider transaction detected by Akkaraju Srinivas
Filed transaction by Mineralys Therapeutics In director. Unconventional Insider trading
Silence Therapeutics Valuation on December 31, 2022
It is possible to determine the worth of Silence Therapeutics on a given historical date. On December 31, 2022 Silence was worth 15.42 at the beginning of the trading date compared to the closed value of 15.25. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Silence Therapeutics stock. Still, in general, we apply an absolute valuation method to find Silence Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Silence Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Silence Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 15.25 | 16.32 | 14.23 | 15.80 | 25,837 | |
12/30/2022 | 15.42 | 16.64 | 14.94 | 15.25 | 24,702 |
| 15.00 | 15.59 | 14.50 | 14.69 | 25,581 |
| Backtest Silence Therapeutics | | | Silence Therapeutics History | | | Silence Therapeutics Valuation | Previous | Next |
Silence Therapeutics Trading Date Momentum on December 31, 2022
| On January 03 2023 Silence Therapeutics PLC was traded for 14.69 at the closing time. Highest Silence Therapeutics's price during the trading hours was 15.59 and the lowest price during the day was 14.50 . The net volume was 25.6 K. The overall trading history on the 3rd of January contributed to the next trading period price depreciation. The trading price change to the next next day price was 3.67% . The trading price change to current price is 3.21% . |
Silence Therapeutics PLC Fundamentals Correlations and Trends
By evaluating Silence Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Silence Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Silence financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Silence Therapeutics Stock history
Silence Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Silence is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Silence Therapeutics PLC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Silence Therapeutics stock prices may prove useful in developing a viable investing in Silence Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 37.1 M | 38.9 M | |
| Net Loss | -36.4 M | -38.3 M |
Silence Therapeutics Quarterly Net Working Capital |
|
Silence Therapeutics Stock Technical Analysis
Silence Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Silence Therapeutics Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Silence Therapeutics PLC cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Silence Therapeutics November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Silence Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Silence Therapeutics shares will generate the highest return on investment. By undertsting and applying Silence Therapeutics stock market strength indicators, traders can identify Silence Therapeutics PLC entry and exit signals to maximize returns
Silence Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Silence Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Silence Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Silence to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (1.18) | |||
| Total Risk Alpha | (1.94) | |||
| Treynor Ratio | (0.68) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Silence Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Silence Therapeutics. If investors know Silence will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Silence Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.69) | Revenue Per Share 0.429 | Quarterly Revenue Growth (0.93) | Return On Assets (0.22) | Return On Equity (0.64) |
The market value of Silence Therapeutics PLC is measured differently than its book value, which is the value of Silence that is recorded on the company's balance sheet. Investors also form their own opinion of Silence Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Silence Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Silence Therapeutics' market value can be influenced by many factors that don't directly affect Silence Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Silence Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Silence Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Silence Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.